General Steel Holdings, Inc. operates a portfolio of Chinese steel companies. The Company serves various industries and produces a range of steel products, including reinforced bars (rebar), hot-rolled sheets and high-speed wire. The Company has four regional divisions in the People’s Republic of China (PRC): Longmen Joint Venture in Shaanxi province, Maoming Hengda in Guangdong province, Baotou Steel Pipe Joint Venture in Inner Mongolia province and General Steel (China) in Tianjin City. It has controlling interests in three steel-related subsidiaries and one Internet of Things (IoT) technology company: General Steel (China) Co., Ltd. (General Steel (China), Shaanxi Longmen Iron and Steel Co., Ltd. (Longmen Joint Venture), Maoming Hengda Steel Co., Ltd. (Maoming Hengd), and Tianjin General Shengyuan IoT Technology Co., Ltd. (General Shengyuan IoT).
General Steel Holdings, Inc. operates a portfolio of Chinese steel companies. The Company serves various industries and produces a range of steel products, including reinforced bars (rebar), hot-rolled sheets and high-speed wire. The Company has four regional divisions in the People’s Republic of China (PRC): Longmen Joint Venture in Shaanxi province, Maoming Hengda in Guangdong province, Baotou Steel Pipe Joint Venture in Inner Mongolia province and General Steel (China) in Tianjin City. It has controlling interests in three steel-related subsidiaries and one Internet of Things (IoT) technology company: General Steel (China) Co., Ltd. (General Steel (China), Shaanxi Longmen Iron and Steel Co., Ltd. (Longmen Joint Venture), Maoming Hengda Steel Co., Ltd. (Maoming Hengd), and Tianjin General Shengyuan IoT Technology Co., Ltd. (General Shengyuan IoT).
Kingsway Financial Services Inc. focuses on non-standard automobile insurance in North America. Kingsway’s primary businesses are the insuring of automobile risks for drivers who do not meet the criteria for coverage by standard automobile insurers, and commercial automobile insurance.
Kingsway Financial Services Inc. focuses on non-standard automobile insurance in North America. Kingsway’s primary businesses are the insuring of automobile risks for drivers who do not meet the criteria for coverage by standard automobile insurers, and commercial automobile insurance.
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways important to cancer cells. It has three clinical-stage product candidates and many preclinical programs that target kinases, cellular metabolism or cell division. The Company’s lead product candidate, rigosertib, is being tested as a single agent and in combination with azacitidine, in clinical trials of patients with myelodysplastic syndromes (MDS) and related cancers.
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways important to cancer cells. It has three clinical-stage product candidates and many preclinical programs that target kinases, cellular metabolism or cell division. The Company’s lead product candidate, rigosertib, is being tested as a single agent and in combination with azacitidine, in clinical trials of patients with myelodysplastic syndromes (MDS) and related cancers.
A leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug Endu in the rapidly growing China market. Our strategic focus is to introduce first-to-market generic and innovative pharmaceutical products for the treatment of diseases with high incidence.
A leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug Endu in the rapidly growing China market. Our strategic focus is to introduce first-to-market generic and innovative pharmaceutical products for the treatment of diseases with high incidence.
Theragenics Corporation® is a medical device company serving the surgical products and prostate cancer treatment markets. Its surgical products business manufactures and distributes wound closure, vascular access, and specialty needle products.
Theragenics Corporation® is a medical device company serving the surgical products and prostate cancer treatment markets. Its surgical products business manufactures and distributes wound closure, vascular access, and specialty needle products.